Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.

Chris Byrne; Lewis J. Beer; Sarah K Inglis; Andrew Radley; John F Dillon

Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.

Chris Byrne, Lewis J. Beer, Sarah K Inglis, Andrew Radley, John F Dillon

Health and Clinical Services

Research output: Contribution to conference › Poster › peer-review

Original language	English
Number of pages	1
Publication status	Published - 19 Sept 2018
Event	International Network on Health and Hepatitis in Substance Users - Portugal, Cascais, Portugal Duration: 19 Sept 2018 → 21 Sept 2018

Conference

Conference	International Network on Health and Hepatitis in Substance Users
Abbreviated title	INHSU
Country/Territory	Portugal
City	Cascais
Period	19/09/18 → 21/09/18

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/4afe008e88ec4f43ae3df118ffe8fc65Licence: No Licence / Unknown

Cite this

Byrne, C., Beer, L. J., Inglis, S. K., Radley, A., & Dillon, J. F. (2018). Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.. Poster session presented at International Network on Health and Hepatitis in Substance Users, Cascais, Portugal. https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/4afe008e88ec4f43ae3df118ffe8fc65

Byrne, Chris ; Beer, Lewis J. ; Inglis, Sarah K et al. / Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial. Poster session presented at International Network on Health and Hepatitis in Substance Users, Cascais, Portugal.1 p.

@conference{a424e1ab61044272935b81849e1ad04a,

title = "Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.",

author = "Chris Byrne and Beer, {Lewis J.} and Inglis, {Sarah K} and Andrew Radley and Dillon, {John F}",

year = "2018",

month = sep,

day = "19",

language = "English",

note = "International Network on Health and Hepatitis in Substance Users, INHSU ; Conference date: 19-09-2018 Through 21-09-2018",

}

Byrne, C, Beer, LJ, Inglis, SK , Radley, A & Dillon, JF 2018, 'Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.', International Network on Health and Hepatitis in Substance Users, Cascais, Portugal, 19/09/18 - 21/09/18. <https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/4afe008e88ec4f43ae3df118ffe8fc65>

Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial. / Byrne, Chris; Beer, Lewis J.; Inglis, Sarah K et al.
2018. Poster session presented at International Network on Health and Hepatitis in Substance Users, Cascais, Portugal.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Pharmacological Monitoring of Participants Undergoing DAA Treatment for Hepatitis C Infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDOT-C trial.

AU - Byrne, Chris

AU - Beer, Lewis J.

AU - Inglis, Sarah K

AU - Radley, Andrew

AU - Dillon, John F

PY - 2018/9/19

Y1 - 2018/9/19

M3 - Poster

T2 - International Network on Health and Hepatitis in Substance Users

Y2 - 19 September 2018 through 21 September 2018

ER -